FdaApplication
ANDA 202024
Identifiers
- fda_app_no: ANDA202024
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS |
| application_type | ANDA |
| approval_date | 2012-03-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GABAPENTIN | GABAPENTIN | 250MG/5ML | SOLUTION;ORAL |
1 product